Results for &quot;&quot;Plasmalogens&quot;&quot;[mesh_terms]

Plasmalogen lipids: functional mechanism and their involvement in gastrointestinal cancer.

Márcia Cristina Fernandes Messias, Giovana Colozza Mecatti, Denise Gonçalves Priolli, Patrícia de Oliveira Carvalho

Lipids in health and disease 2018;17(1):41

A new test method for biochemical analysis of plasmalogens in dried blood spots and erythrocytes from patients with peroxisomal disorders.

Silvia Tortorelli, Kimiyo M Raymond, Nancy E Braverman, Dimitar K Gavrilov, Stephanie D Stoway, Amy L White, Peter J Wegwerth, Dietrich Matern, Devin Oglesbee, Perry R Loken

Journal of inherited metabolic disease 2023;46(6):1159-1169

Change of plasmalogen content of red blood cells in myocardial hypoxia and acidosis.

Alexander Nikolaevich Osipenko

Acta cardiologica 2019;73(1):61-68

Lipid alterations in the earliest clinically recognizable stage of Alzheimer's disease: implication of the role of lipids in the pathogenesis of Alzheimer's disease.

Xianlin Han

Current Alzheimer research 2005;2(1):65-77

Peroxisomal disorders: the single peroxisomal enzyme deficiencies.

Ronald J A Wanders, Hans R Waterham

Biochimica et biophysica acta 2007;1763(12):1707-20

Serum Levels of Plasmalogens and Fatty Acid Metabolites Associate with Retinal Microangiopathy in Participants from the Finnish Diabetes Prevention Study.

Vanessa Derenji de Mello, Tuomas Selander, Jaana Lindström, Jaakko Tuomilehto, Matti Uusitupa, Kai Kaarniranta

Nutrients 2022;13(12):

Vitamin B12 Attenuates Changes in Phospholipid Levels Related to Oxidative Stress in SH-SY5Y Cells.

Elena Leoni Theiss, Marcus Otto Walter Grimm, Tobias Hartmann, Heike Sabine Grimm, Dorothea Portius, Konstantin Nicolas Kuppler, Lea Victoria Griebsch, Anna Andrea Lauer, Daniel Janitschke, Vincent Konrad Johannes Erhardt, Elodie Christiane Haas, Juliane Radermacher, Oliver Walzer

Cells 2022;11(16):2574

Phenotypic variability (heterogeneity) of peroxisomal disorders.

Hanna Mandel, Stanley H Korman

Advances in experimental medicine and biology 2004;544():9-30

Neonatal adrenoleukodystrophy: a clinical, pathologic, and biochemical study.

Donald F Farrell

Pediatric neurology 2013;47(5):330-6

Plasma lipid profile associates with the improvement of psychological well-being in individuals with perceived stress symptoms.

Stefania Noerman, Anton Klåvus, Elina Järvelä-Reijonen, Leila Karhunen, Seppo Auriola, Riitta Korpela, Raimo Lappalainen, Urho M Kujala, Sampsa Puttonen, Marjukka Kolehmainen, Kati Hanhineva

Scientific reports 2020;10(1):2143

Peroxisome biogenesis disorders.

Steven J Steinberg, Gabriele Dodt, Gerald V Raymond, Nancy E Braverman, Ann B Moser, Hugo W Moser

Biochimica et biophysica acta 2007;1763(12):1733-48

Peroxisomal regulation of energy homeostasis: Effect on obesity and related metabolic disorders.

Brian Kleiboeker, Irfan J Lodhi

Molecular metabolism 2022;65():101577

Development and validation of a plasmalogen score as an independent modifiable marker of metabolic health: population based observational studies and a placebo-controlled cross-over study.

John Beilby, Sudip Paul, Eric K Moses, Joseph Hung, Jennie Hui, Corey Giles, Natalie A Mellett, Kevin Huynh, Peter J Meikle, Tingting Wang, John Blangero, Gerald F Watts, Dianna J Magliano, Jonathan E Shaw, Thomas G Meikle, Habtamu B Beyene, Michelle Cinel, Gavriel Olshansky

EBioMedicine 2024;105():105187

Myo-inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome.

Ryouta Maeba, Hiroshi Hara, Hiroshi Ishikawa, Shigeru Hayashi, Nakayuki Yoshimura, Jyun Kusano, Yoko Takeoka, Daijiro Yasuda, Tomoki Okazaki, Makoto Kinoshita, Tamio Teramoto

Journal of nutritional science and vitaminology 2008;54(3):196-202